A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

NCT01105624 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Contact Lens Dry Eye

Interventions

DRUG: azithromycin ophthalmic solution, 1%
DRUG: Visine® for Contacts®

Sponsor

Merck Sharp & Dohme LLC